Stockreport

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF initiate dose escalation; dosing of first patient in cohort two (high dose, n=3) expected in Q2 2024 REVEAL adolescent and adult trial will now expand into the U.S. fo [Read more]